Herpes zoster post covid-19 vaccination
Javeria Hafeez, Sakina Sadiq Malik, Uzma Bashir, Ayesha Hafeez, Aqsa Naheed, Tehseen Naveed
96
ABSTRACT
Aim: To find
out association of herpes zoster and changes in disease course like incidence
of post-herpetic neuralgia with Covid-19 vaccination.
Study design: Cross-sectional,
observational study.
Place and duration of study: Outpatient
Department of Dermatology, CMH and PEMH Rawalpindi from 1st January
2021 to 30th September 2021.
Methodology: Seventy
three patients presenting with herpes
zoster selected by convenience sampling after their verbal and written consent.
Demographics, Covid-19 vaccination history, type of vaccination, dermatome
effected, co-morbids and presence of post herpetic neuralgia were recorded in
them.
Results: Mean
age of participants was 48.09±15.73 years with 50 (68.5%) were males and 23
(31.5%) were females. 33 (45.2%) were vaccinated and 36 (49.3%) were
non-vaccinated against covid-19. Maximum patients were vaccinated with
Sinopharm i.e. 19(57.6%).8 (24.2%) patients developed the lesions after first
dose and 25(75.8%) after 2nd dose of vaccination.
Conclusion:
Herpes zoster risk is increased
with covid-19 vaccination.
Key
words: Herpes Zoster, Covid-19 vaccination.
ABSTRACT
Aim: To find
out association of herpes zoster and changes in disease course like incidence
of post-herpetic neuralgia with Covid-19 vaccination.
Study design: Cross-sectional,
observational study.
Place and duration of study: Outpatient
Department of Dermatology, CMH and PEMH Rawalpindi from 1st January
2021 to 30th September 2021.
Methodology: Seventy
three patients presenting with herpes
zoster selected by convenience sampling after their verbal and written consent.
Demographics, Covid-19 vaccination history, type of vaccination, dermatome
effected, co-morbids and presence of post herpetic neuralgia were recorded in
them.
Results: Mean
age of participants was 48.09±15.73 years with 50 (68.5%) were males and 23
(31.5%) were females. 33 (45.2%) were vaccinated and 36 (49.3%) were
non-vaccinated against covid-19. Maximum patients were vaccinated with
Sinopharm i.e. 19(57.6%).8 (24.2%) patients developed the lesions after first
dose and 25(75.8%) after 2nd dose of vaccination.
Conclusion:
Herpes zoster risk is increased
with covid-19 vaccination.
Key
words: Herpes Zoster, Covid-19 vaccination.